메뉴 건너뛰기




Volumn 42, Issue 7, 2014, Pages 1747-1748

Selepressin in septic shock: Sharpening the VASST effects of vasopressin?

Author keywords

capillary leak syndrome; selepressin; sepsis; vasoconstrictor agents; vasopressin

Indexed keywords

DESMOPRESSIN; FE 202158; SELEPRESSIN; UNCLASSIFIED DRUG; VASOPRESSIN;

EID: 84902472609     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000420     Document Type: Editorial
Times cited : (8)

References (13)
  • 1
    • 84902551843 scopus 로고    scopus 로고
    • The selective vasopressin type 1a receptor agonist selepressin (FE 202158) Blocks vascular leak in ovine severe sepsis
    • Maybauer MO, Maybauer DM, Enkhbaatar P, et al: The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis. Crit Care Med 2014; 42:e525-e533
    • (2014) Crit Care Med , vol.42
    • Maybauer, M.O.1    Maybauer, D.M.2    Enkhbaatar, P.3
  • 2
    • 0031026648 scopus 로고    scopus 로고
    • Vasopressin deficiency contributes to the vasodilation of septic shock
    • Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
    • (1997) Circulation , vol.95 , pp. 1122-1125
    • Landry, D.W.1    Levin, H.R.2    Gallant, E.M.3
  • 3
    • 34347383381 scopus 로고    scopus 로고
    • Vasopressin in vasodilatory and septic shock
    • Russell JA: Vasopressin in vasodilatory and septic shock. Curr Opin Crit Care 2007; 13:383-391
    • (2007) Curr Opin Crit Care , vol.13 , pp. 383-391
    • Russell, J.A.1
  • 4
    • 84875133181 scopus 로고    scopus 로고
    • A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock
    • Daley MJ, Lat I, Mieure KD, et al: A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock. Ann Pharmacother 2013; 47:301-310
    • (2013) Ann Pharmacother , vol.47 , pp. 301-310
    • Daley, M.J.1    Lat, I.2    Mieure, K.D.3
  • 5
    • 3543092016 scopus 로고    scopus 로고
    • Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock
    • Hall LG, Oyen LJ, Taner CB, et al: Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacotherapy 2004; 24:1002-1012
    • (2004) Pharmacotherapy , vol.24 , pp. 1002-1012
    • Hall, L.G.1    Oyen, L.J.2    Taner, C.B.3
  • 6
    • 33750201277 scopus 로고    scopus 로고
    • Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial
    • Lauzier F, Lévy B, Lamarre P, et al: Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial. Intensive Care Med 2006; 32:1782-1789
    • (2006) Intensive Care Med , vol.32 , pp. 1782-1789
    • Lauzier, F.1    Lévy, B.2    Lamarre, P.3
  • 7
    • 84891608334 scopus 로고    scopus 로고
    • Receptor-selective vasopressin analogs: A new push for decatecholaminization"?
    • Radermacher P, Thiemermann C: Receptor-selective vasopressin analogs: A new push for "decatecholaminization"? Shock 2013; 39:539-540
    • (2013) Shock , vol.39 , pp. 539-540
    • Radermacher, P.1    Thiemermann, C.2
  • 8
    • 40049109098 scopus 로고    scopus 로고
    • Vasopressin versus norepinephrine infusion in patients with septic shock
    • VASST Investigators
    • Russell JA, Walley KR, Singer J, et al; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
    • (2008) N Engl J Med , vol.358 , pp. 877-887
    • Russell, J.A.1    Walley, K.R.2    Singer, J.3
  • 9
    • 84873339299 scopus 로고    scopus 로고
    • Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012
    • Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup
    • Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637
    • (2013) Crit Care Med , vol.41 , pp. 580-637
    • Dellinger, R.P.1    Levy, M.M.2    Rhodes, A.3
  • 10
    • 31344461826 scopus 로고    scopus 로고
    • Sepsis in European intensive care units: Results of the SOAP study
    • Sepsis Occurrence in Acutely Ill Patients Investigators
    • Vincent JL, Sakr Y, Sprung CL, et al; Sepsis Occurrence in Acutely Ill Patients Investigators: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34:344-353
    • (2006) Crit Care Med , vol.34 , pp. 344-353
    • Vincent, J.L.1    Sakr, Y.2    Sprung, C.L.3
  • 11
    • 78651226079 scopus 로고    scopus 로고
    • Role of selective V1a receptor agonism in ovine septic shock
    • Rehberg S, Ertmer C, Vincent JL, et al: Role of selective V1a receptor agonism in ovine septic shock. Crit Care Med 2011; 39:119-125
    • (2011) Crit Care Med , vol.39 , pp. 119-125
    • Rehberg, S.1    Ertmer, C.2    Vincent, J.L.3
  • 12
    • 84902482561 scopus 로고    scopus 로고
    • 123: Early administration of the selective V1a receptor agonist selepressin is superior to arginine vasopressin or norepinephrine in a sheep model of septic shock
    • Su F, He X, Taccone FS, et al. 123: Early administration of the selective V1a receptor agonist selepressin is superior to arginine vasopressin or norepinephrine in a sheep model of septic shock. Crit Care Med 2012; 40:1-328
    • (2012) Crit Care Med , vol.40 , pp. 1-328
    • Su, F.1    He, X.2    Taccone, F.S.3
  • 13
    • 84869159866 scopus 로고    scopus 로고
    • Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis
    • Rehberg S, Yamamoto Y, Sousse L, et al: Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis. Am J Physiol Heart Circ Physiol 2012; 303:123
    • (2012) Am J Physiol Heart Circ Physiol , vol.303 , pp. 123
    • Rehberg, S.1    Yamamoto, Y.2    Sousse, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.